The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients
Authors:
- 4 October 2012
- journal article
- research article
- Published by Springer Nature in Lasers in Medical Science
- Vol. 28 (4) , 1151-1157
Abstract
The purpose of this study is to evaluate the safety and efficacy of 120-W potassium titanyl phosphate (KTP) laser vaporization in patients with benign prostatic hyperplasia (BPH) who also had cardiopulmonary diseases who were taking long-term anticoagulants and were at high risk of bleeding complications. The prospective study included 188 patients with severe lower urinary tract symptoms who underwent 120-W KTP laser vaporization of the prostate. All patients were at high cardiopulmonary risk, having presented with an American Society of Anesthesiology score of 3 or greater. Of those, 45 patients were taking oral anticoagulants, and 1 had a severe bleeding disorder. BPH was successfully treated with 120-W KTP laser vaporization in all patients. Mean preoperative prostate volume ± SD was 66 ± 23.1 ml, and mean operative time was 50.8 ± 15.5 min. There were no major complications intraoperatively or postoperatively, and no blood transfusions were required. Postoperatively, only 14 patients (7.4 %) required bladder irrigation. Average catheterization time was 1.9 ± 1.5 days (range, 1–5 days). Three patients required reoperation due to enlarged prostates from residual adenoma. At 3-, 6,- 12-, and 24-month follow-ups, mean urinary peak flow increased from 8.0 ± 3.6 ml/s to 19.1 ± 5.6, 19.2 ± 4.7, 19.1 ± 4.65, and 19.2 ± 4.34 ml/s, respectively. Mean International Prostate Symptom Scores decreased over time, from 25.6 ± 5.1 (3 months) to 9.4 ± 2.8, 7.05 ± 1.46, 6.24 ± 1.36, and 6.20 ± 1.32 (24 months), respectively. 120-W HPS KTP laser vaporization is a safe and effective treatment option in BPH patients at high risk and those on anticoagulation therapy who have severe LUTS secondary to BPH.Keywords
This publication has 36 references indexed in Scilit:
- High-performance system GreenLight laser: indications and outcomesCurrent Opinion in Urology, 2009
- Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non‐randomized two‐centre studyBJU International, 2008
- Comparison of Photoselective Vaporization of the Prostate and Transurethral Resection of the Prostate: A Prospective Nonrandomized Bicenter Trial with 2-Year Follow-UpJournal of Endourology, 2008
- Rapid Communication : Photoselective Vaporization of the Prostate versus Transurethral Resection of the Prostate for the Large Prostate: A Prospective Nonrandomized Bicenter Trial with 2-Year Follow-UpJournal of Endourology, 2008
- The Evolution of KTP Laser Vaporization of the ProstateYonsei Medical Journal, 2008
- Outcomes of 80 W KTP Laser Vaporization of the Large ProstateUrologia Internationalis, 2007
- Photoselective Vaporization (PVP) versus Transurethral Resection of the Prostate (TURP): A Prospective Bi-Centre Study of Perioperative Morbidity and Early Functional OutcomeEuropean Urology, 2005
- Short Term Outcomes of High Power (80 W) Potassium-titanyl-phosphate Laser Vaporization of the ProstateEuropean Urology, 2005
- Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related SurgeryEuropean Urology, 2003
- Interstitial Laser Therapy Outcomes in Benign Prostatic HyperplasiaJournal of Endourology, 1995